IL-6
Tocilizumab is a monoclonal antibody that acts as an IL-6 receptor antagonist. It is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, and cytokine release syndrome. By blocking IL-6 receptors, it reduces inflammation and immune system activity.